News

Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
Jim Cramer is Confident “Someone Will Want Some of Kenvue”
Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Express Healthcare1d
Kenvue and API launch India’s first cough clinics to standardise cough diagnosis and treatment
Benadryl maker Kenvue partners with the Association of Physicians of India to open Centres of Excellence for clinical ...
Rediff Money17h
India's 1st Cough Clinics Launched by Kenvue & API
Kenvue and API launch India's first Cough Clinics to improve cough diagnosis and treatment. The initiative aims to address ...
Business Wire4d
Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value
Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company ...
Explore more
Barchart on MSN2d
Kenvue's Q2 2025 Earnings: What to Expect
Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip.
Kenvue Inc. stock rises Wednesday, outperforms market
Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.